Suchergebnisse - "De Giorgi, Ugo"

PubPharm (596)

41

AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer

enthalten in: Breast cancer research | 2023

von Campone, M. | Bidard, F. | Neven, P. | +6

42

Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab

enthalten in: JAMA network open | 2023

von Catalano, M. | Rebuzzi, S. | Maruzzo, M. | +31

43

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

enthalten in: The New England journal of medicine | 2023

von Freedland, S. | de Almeida Luz, M. | De Giorgi, U. | +17

CommentIn: N Engl J Med. 2024 Jan 4;390(1):90. - PMID 38169497

44

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma

enthalten in: European urology open science | 2023

von Fankhauser, C. | Jandari, A. | Collette, L. | +10

45

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

enthalten in: Clinical genitourinary cancer | 2023

von Santoni, M. | Massari, F. | Myint, Z. | +53

46

Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer

enthalten in: British journal of cancer | 2023

von Conteduca, V. | Brighi, N. | Schepisi, G. | +1

47

Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab

enthalten in: Critical reviews in oncology/hematology | 2023

von Debien, V. | Marta, G. | Agostinetto, E. | +16

48

Prescribing pattern of anticoagulants in patients with cancer associated thrombosis : Results of a survey among MITO group and AIOM society

enthalten in: Tumori | 2023

von Milani, A. | Tuninetti, V. | Pignata, S. | +16

49

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

enthalten in: Clinical pharmacology and therapeutics | 2023

von Polano, M. | Bedon, L. | Dal Bo, M. | +19

50

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Santoni, M. | Myint, Z. | Büttner, T. | +40